Asked by: Dan Norris (Independent - North East Somerset and Hanham)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what progress is being made to improve North East Somerset & Hanham patient access to GPs.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
We are expanding capacity in general practice and delivering more appointments to patients. North East Somerset and Hanham sit within the NHS Somerset Integrated Care Board area, which has seen a 9.4% rise in the number of general practice appointments delivered over the past year, with 304,000 appointments delivered in September 2025 compared to 278,000 appointments delivered in September 2024. This is above the national average increase of 6.6%.
In October 2024, we have invested £160 million into the Additional Roles Reimbursement Scheme and given additional flexibilities to recruit 2,500 new general practitioners into primary care networks across England. We have invested an additional £1.1 billion in general practice to reinforce the front door of the NHS. This is the biggest increase in over a decade. Additionally, the new £102 million Primary Care Utilisation and Modernisation Fund will create additional clinical space within over 1,000 general practices across England to deliver 8.3 million more appointments each year.
Asked by: Jim Shannon (Democratic Unionist Party - Strangford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many GP appointments are offered in England each week.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
General practice appointment data is collected and published monthly by NHS England. This data records appointments that have actually taken place, rather than those offered. As a result, we are unable to ascertain precisely how many appointments are offered to patients, we can, however, report on the number delivered.
In September 2025, 32 million appointments were delivered, which is, on average, approximately eight million appointments delivered in general practice per week.
Asked by: Iqbal Mohamed (Independent - Dewsbury and Batley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, when his Department will respond to the letter from the hon. Member for Dewsbury and Batley dated 17 September 2025.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
I replied to the Hon. Member’s correspondence on 19 November.
Asked by: Jim Shannon (Democratic Unionist Party - Strangford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many people have received cornea transplants aged under 18 in each of the last 3 years.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
In the last three years, there has been a total of 469 finished consultant episodes recorded where there was any procedure of ‘other corneal graft procedure’ for patients aged zero to 17 years old, when accounting for activity in English National Health Service hospitals and English NHS commissioned activity in the private sector. By year there were:
This information has been gathered from the Hospital Episode Statistics dataset, which is published by NHS England.
Asked by: Marie Goldman (Liberal Democrat - Chelmsford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will take steps to ensure that dentists have adequate knowledge and training to treat people born with cleft (a) lips and (b) palates.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
I refer the Hon. Member to the answer I gave to the Hon. Member for Yeovil on 20 November 2025 to Question 90537.
Asked by: Helen Maguire (Liberal Democrat - Epsom and Ewell)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to increase early detection of mouth cancer.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
To help increase the early detection of cancer, the Government has recently launched Jess’s Rule, an initiative that asks general practitioners (GPs) to think again if, after three appointments, they have been unable to diagnose a patient, or if their symptoms have escalated.
The Department is also investing an additional £889 million in GPs, bringing total spend on the GP Contract to £13.2 billion in 2025/26. This will help to ensure the National Health Service has a well-trained and well-equipped primary care service that can take the time to provide quality care to patients around the country.
Dentists and other dental professionals, including hygienists, routinely check the soft tissues of a patient’s mouth for signs of cancer during dental visits and as part of the check-up will make an assessment and record an individual’s oral cancer risk. Dentists will prioritise patients at a higher risk of oral cancer for more frequent recall and review in line with National Institute for Health and Care Excellence guidance.
Additionally, NHS England is working in partnership with major supermarket chains to include messages about common cancer symptoms onto the packaging of relevant products. This has included specific messaging on mouth cancer symptoms on toothpaste and mouthwash packaging.
To support earlier and faster cancer diagnosis, the NHS is now delivering additional checks, tests, and scans at 170 community diagnostic centres.
Cancer incidence, including mouth cancer, is increasing. The Government is taking action, including raising awareness of signs and symptoms and focusing on prevention, such as the introduction of the Tobacco and Vapes Bill.
Asked by: Helen Maguire (Liberal Democrat - Epsom and Ewell)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to reduce cases of mouth cancer.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
To help increase the early detection of cancer, the Government has recently launched Jess’s Rule, an initiative that asks general practitioners (GPs) to think again if, after three appointments, they have been unable to diagnose a patient, or if their symptoms have escalated.
The Department is also investing an additional £889 million in GPs, bringing total spend on the GP Contract to £13.2 billion in 2025/26. This will help to ensure the National Health Service has a well-trained and well-equipped primary care service that can take the time to provide quality care to patients around the country.
Dentists and other dental professionals, including hygienists, routinely check the soft tissues of a patient’s mouth for signs of cancer during dental visits and as part of the check-up will make an assessment and record an individual’s oral cancer risk. Dentists will prioritise patients at a higher risk of oral cancer for more frequent recall and review in line with National Institute for Health and Care Excellence guidance.
Additionally, NHS England is working in partnership with major supermarket chains to include messages about common cancer symptoms onto the packaging of relevant products. This has included specific messaging on mouth cancer symptoms on toothpaste and mouthwash packaging.
To support earlier and faster cancer diagnosis, the NHS is now delivering additional checks, tests, and scans at 170 community diagnostic centres.
Cancer incidence, including mouth cancer, is increasing. The Government is taking action, including raising awareness of signs and symptoms and focusing on prevention, such as the introduction of the Tobacco and Vapes Bill.
Asked by: Sarah Hall (Labour (Co-op) - Warrington South)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what the timetable is for implementing the National Screening Committee’s In-Service Evaluation of newborn screening for spinal muscular atrophy; what the duration of the evaluation will be; and when the NSC expects to reach a recommendation on whether SMA should be added to the newborn blood spot screening programme.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
On all aspects of population and targeted screening, Ministers are advised by the UK National Screening Committee (UK NSC).
The UK NSC recommended an in-service evaluation (ISE) of newborn blood spot screening for spinal muscular atrophy (SMA) in National Health Services in 2023. Since then, the SMA Newborn Screening ISE Partnership Board was set up to plan and develop work to shape the ISE, and progress is being made. This includes planning the duration of the ISE and planning for newborn laboratories to screen blood spot samples for SMA. The laboratories in England that will form part of the ISE are under consideration by the SMA partnership board led by NHS England. The researchers and the National Institute for Health and Research (NIHR) will be responsible for determining the number of babies and services that will be required to answer the research questions.
Earlier in the year, the NIHR published their Health Technology Assessment research brief to appoint researchers for this work. Applications closed at the end of September 2025, and final funding decisions are expected in spring 2026. A decision on the shape and roll out of the ISE will be made after the research call process has concluded.
A recommendation by the UK NSC on newborn screening for SMA is expected following the conclusion of an ISE, which is needed to answer several outstanding questions related to the implementation of a screening programme for SMA.
Asked by: Andy MacNae (Labour - Rossendale and Darwen)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what his planned timeline is for the data collection, evaluation and interim decision for the in-service evaluation of newborn screening for spinal muscular atrophy.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
On all aspects of population and targeted screening, Ministers are advised by the UK National Screening Committee (UK NSC).
The UK NSC recommended an in-service evaluation (ISE) of newborn blood spot screening for spinal muscular atrophy (SMA) in National Health Services in 2023. Since then, the SMA Newborn Screening ISE Partnership Board was set up to plan and develop work to shape the ISE, and progress is being made. This includes planning the duration of the ISE and planning for newborn laboratories to screen blood spot samples for SMA. The laboratories in England that will form part of the ISE are under consideration by the SMA partnership board led by NHS England. The researchers and the National Institute for Health and Research (NIHR) will be responsible for determining the number of babies and services that will be required to answer the research questions.
Earlier in the year, the NIHR published their Health Technology Assessment research brief to appoint researchers for this work. Applications closed at the end of September 2025, and final funding decisions are expected in spring 2026. A decision on the shape and roll out of the ISE will be made after the research call process has concluded.
A recommendation by the UK NSC on newborn screening for SMA is expected following the conclusion of an ISE, which is needed to answer several outstanding questions related to the implementation of a screening programme for SMA.
Asked by: Andy MacNae (Labour - Rossendale and Darwen)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how newborn screening laboratories can join the in-service evaluation of newborn screening for spinal muscular atrophy.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
On all aspects of population and targeted screening, Ministers are advised by the UK National Screening Committee (UK NSC).
The UK NSC recommended an in-service evaluation (ISE) of newborn blood spot screening for spinal muscular atrophy (SMA) in National Health Services in 2023. Since then, the SMA Newborn Screening ISE Partnership Board was set up to plan and develop work to shape the ISE, and progress is being made. This includes planning the duration of the ISE and planning for newborn laboratories to screen blood spot samples for SMA. The laboratories in England that will form part of the ISE are under consideration by the SMA partnership board led by NHS England. The researchers and the National Institute for Health and Research (NIHR) will be responsible for determining the number of babies and services that will be required to answer the research questions.
Earlier in the year, the NIHR published their Health Technology Assessment research brief to appoint researchers for this work. Applications closed at the end of September 2025, and final funding decisions are expected in spring 2026. A decision on the shape and roll out of the ISE will be made after the research call process has concluded.
A recommendation by the UK NSC on newborn screening for SMA is expected following the conclusion of an ISE, which is needed to answer several outstanding questions related to the implementation of a screening programme for SMA.